Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs

Research in Veterinary Science

Volumn 80, Issue 3, 2006, Pages 336-342

  Pedersen, L G ^a   Tarnow, I ^a   Olsen, L H ^a   Teerlink, T ^b   Pedersen, H D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ADMA; Body weight; Creatinine; Dog; L arginine; Physiology; SDMA

Indexed keywords

ARGININE; CREATININE; N(G),N(G) DIMETHYLARGININE; SYMMETRIC DIMETHYLARGININE; UNCLASSIFIED DRUG;

AGE; AMINO ACID BLOOD LEVEL; ARTICLE; BODY WEIGHT; BREED DIFFERENCE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DOG; DOG DISEASE; FEMALE; HEART MURMUR; HUMAN VERSUS ANIMAL COMPARISON; LEAN BODY WEIGHT; MALE; MITRAL VALVE REGURGITATION; NONHUMAN; OBESITY;

AGE FACTORS; ANIMALS; ARGININE; BODY WEIGHT; CREATININE; DOG DISEASES; DOGS; FEMALE; LINEAR MODELS; MALE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; SEX FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 32144452905     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2005.07.005     Document Type: Article

References (44)

1. F. Abbasi T. Asagmi J.P. Cooke C. Lamendola T. McLaughlin G.M. Reaven M. Stuehlinger P.S. Tsao Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus Am. J. Cardiol. 88 2001 1201-1203
2. V. Achan M. Broadhead M. Malaki G. Witley J. Leipe R. MacAllister P. Vallance Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethyl dimethylaminohydrolase Arterioscler. Thromb. Vasc. Biol. 23 2003 1455-1459
3. B.E. Belshaw The differential diagnosis of polyuria/polydipsia in dogs Vet. Quart. 17 1995 S19-S21
4. R.H. Böger S.M. Bode-Böger A. Szuba P.S. Tsao J.R. Chan O. Tangphao T.F. Blaschke J.P. Cooke Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia Circulation 98 1998 1842-1847
5. J.W. Buchanan Chronic valvular disease (endocardiosis) in dogs Adv. Vet. Sci. Comp. Med. 21 1977 75-106
6. J.W. Chen N.W. Hsu T.C. Wu S.J. Lin M.S. Chang Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X Am. J. Cardiol. 90 2002 974-982
7. S. Clarke Protein methylation Curr. Opin. Cell. Biol. 5 1993 977-983
8. J.P. Cooke Does ADMA cause endothelial dysfunction? Arterioscler. Thromb. Vasc. Biol. 20 2000 2032-2037
9. J.P. Cooke Asymmetrical dimethylarginine. The Über marker? Circulation 109 2004 1813-1819
10. D.K. Detweiler D.F. Patterson The prevalence and types of cardiovascular disease in dogs Ann. N.Y. Acad. Sci. 127 1965 481-516
11. H.M.A. Eid H. Arnesen E.M. Hjerkinn T. Lyberg I. Seljeflot Relationship between obesity, smoking, and endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine Metabolism 53 2004 1574-1579
12. J.E. Eigenmann D.F. Patterson E.R. Froesch Body size parallels insulin-like growth factor I levels but not growth hormone secretory capacity Acta Endocrinol. (Copenh.) 106 1984 448-453
13. J. Ellis U. Wennerholm A. Bengtsson H. Lilja A. Pettersson B. Sultan M. Wennergren H. Hagberg Levels of dimethylarginines and cytokines in mild and severe preeclampsia Acta Obstet. Gynecol. Scand. 80 2001 208-602
14. C. Fleck A. Janz F. Schweitzer E. Karge M. Schwertfeger G. Stein Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients Kidney. Int. 59 2001 14-18
15. C. Fleck F. Schweitzer E. Karge N. Busch G. Stein Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases Clin. Chim. Acta 336 2003 1-12
16. J. Häggström K. Hansson B.E. Karlberg C. Kvart K. Olsson Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels Am. J. Vet. Res. 55 1994 698-703
17. A. Ito P.S. Tsao S. Adimoolam M. Kimoto T. Ogawa J.P. Cooke Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase Circulation 99 1999 3092-3095
18. T.C. Jones B.C. Zook Aging changes in the vascular system of animals Ann. N.Y. Acad. Sci. 127 1965 671-684
19. J.T. Kielstein R.H. Böger S.M. Bode-Böger J. Schäffer M. Barbey K.H. Koch J.C. Frählich Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease J. Am. Soc. Nephrol. 10 1999 594-600
20. J.T. Kielstein S.M. Bode-Böger J.C. Frälich E. Ritz H. Haller D. Fliser Asymmetric dimethylarginine, blood pressure and renal perfusion in elderly subjecs Circulation 107 2003 1891-1895
21. J.T. Kielstein S.M. Bode-Böger G. Klein S. Graf H. Haller D. Fliser Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure Eur. J. Clin. Invest. 33 2003 370-375
22. J.T. Kielstein B. Impraim S. Simmel S.M. Bode-Boger D. Tsikas J.C. Frolich M.M. Hoeper H. Haller D. Fliser Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans Circulation 109 2004 172-177
23. K. Krzyzanowska F. Mittermayer H.P. Kopp M. Wolzt G. Schernthaner Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women J. Clin. Endocrinol. Metab. 89 2004 6277-6281
24. T. Laussmann R.A. Janosi C.D. Fingas G.R. Schlieper W. Schlack J. Schrader U.K. Decking Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow FASEB J. 16 2002 628-630
25. R.J. MacAllister M.H. Rambausek P. Vallance D. Williams K.H. Hoffmann E. Ritz Concentration of dimethyl-L-arginine in plasma of patients with end-stage renal failure Nephrol. Dial. Transplant. 11 1996 2449-2452
26. B. Marescau G. Nagels I. Possemiers M.E. De Broe I. Because J.M. Billiouw W. Lornoy P.P. De Deyn Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency Metabolism 46 1997 1024-1031
27. A.E. McBride P.A. Silver State of Arginine: Protein methylation at arginine comes of age Cell 106 2001 5-8
28. G-dimethylarginine in the rabbit Biochem. J. 154 1976 179-184
29. H. Miyazaki H. Matsuoka J.P. Cooke M. Usui S. Ueda S. Okuda T. Imaizumi Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis Circulation 99 1999 1141-1146
30. R.J. Nijveldt P.A.M. van Leeuwen C. van Guldener C.D.A. Stehouwer J.A. Rauwerda T. Teerlink Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans Nephrol. Dial. Transplant. 17 2002 1999-2002
31. G-dimethyl-L-arginine to L-citrulline in rats Biochem. Biophys. Res. Commun. 148 1987 671-677
32. M. Ohnishi A. Wada T. Tsutamoto M. Fujii T. Matsumoto T. Yamamoto T. Takayama X. Wang M. Kinoshita Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure Clin. Sci. (Lond.) 103 2002 241S-244S
33. H.D. Pedersen L.H. Olsen Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions Res. Vet. Sci. 66 1999 11-17
34. H.D. Pedersen K.A. Lorentzen B.Ø. Kristensen Echocardiographic mitral valve prolapse in cavalier King Charles Spaniels: Epidemiology and prognostic significance for regurgitation Vet. Rec. 144 1999 315-320
35. H.D. Pedersen T. Schütt R. Soendergaard K. Qvortrup L.H. Olsen A.T. Kristensen Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation J. Vet. Intern. Med. 17 2003 178-184
36. A. Surdacki M. Nowicki J. Sandmann D. Tsikas R.H. Boeger S.M. Bode-Boeger O. Kruszelnicka-Kwiatkowska F. Kokot J.S. Dubiel J.C. Froelich Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension J. Cardiovasc. Pharmacol. 33 1999 652-658
37. T. Teerlink R.J. Nijveldt S. de Jong P.A.M. van Leeuwen Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography Anal. Biochem. 303 2002 131-137
38. M.V. Thrusfield C.G.G. Aitken P.G.G. Darke Observations on breed and sex in relation to canine heart valve incompetence J. Small Anim. Pract. 26 1985 709-717
39. A. Tidholm J. Häggström M. Borgarelli A. Tarducci Canine idiopathic cardiomyopathy. Part I: Aetiology, clinical characteristics, epidemiology and pathology Vet. J. 162 2001 92-107
40. C.T.L. Tran J.M. Leiper P. Vallance The DDAH/ADMA/NOS pathway Atherosclerosis Suppl. 4 2003 33-40
41. M. Usui H. Matsuoka H. Miyazaki S. Ueda S. Okuda T. Imaizumi Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure Life Sci. 62 1998 2425-2430
42. P. Vallance A. Leone A. Calver J. Collier S. Moncada Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure Lancet 339 1992 572-575
43. X.J. Yu Y.J. Li Y. Xiong Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits Life Sci. 54 1994 753-758
44. B.C. Zook Some spontaneous cardiovascular lesions in dogs and cats Comp. Path. Heart Adv. Cardiol. 13 1974 148-168